353 related articles for article (PubMed ID: 19219856)
1. The role of the brain-derived neurotrophic factor (BDNF) val66met variant in the phenotypic expression of obsessive-compulsive disorder (OCD).
Katerberg H; Lochner C; Cath DC; de Jonge P; Bochdanovits Z; Moolman-Smook JC; Hemmings SM; Carey PD; Stein DJ; Sondervan D; Boer JA; van Balkom AJ; Polman A; Heutink P
Am J Med Genet B Neuropsychiatr Genet; 2009 Dec; 150B(8):1050-62. PubMed ID: 19219856
[TBL] [Abstract][Full Text] [Related]
2. Brain-derived neurotrophic factor Val66Met polymorphism and obsessive-compulsive symptoms in Egyptian schizophrenia patients.
Hashim HM; Fawzy N; Fawzi MM; Karam RA
J Psychiatr Res; 2012 Jun; 46(6):762-6. PubMed ID: 22521161
[TBL] [Abstract][Full Text] [Related]
3. BDNF Val66Met polymorphism and plasma levels in Chinese Han population with obsessive-compulsive disorder and generalized anxiety disorder.
Wang Y; Zhang H; Li Y; Wang Z; Fan Q; Yu S; Lin Z; Xiao Z
J Affect Disord; 2015 Nov; 186():7-12. PubMed ID: 26209750
[TBL] [Abstract][Full Text] [Related]
4. Investigating the role of the brain-derived neurotrophic factor (BDNF) val66met variant in obsessive-compulsive disorder (OCD).
Hemmings SM; Kinnear CJ; Van der Merwe L; Lochner C; Corfield VA; Moolman-Smook JC; Stein DJ
World J Biol Psychiatry; 2008; 9(2):126-34. PubMed ID: 17853300
[TBL] [Abstract][Full Text] [Related]
5. Is Brain-Derived Neurotrophic Factor (BDNF) Val66Met Polymorphism Associated with Obsessive-Compulsive Disorder? A Meta-Analysis.
Wang S; Xu X; Yan P; Song M; Li J; Wang S
Psychiatr Danub; 2019 Jun; 31(2):141-147. PubMed ID: 31291217
[TBL] [Abstract][Full Text] [Related]
6. Variation in the BDNF Val66Met polymorphism and response to cognitive-behavior therapy in obsessive-compulsive disorder.
Fullana MA; Alonso P; Gratacòs M; Jaurrieta N; Jiménez-Murcia S; Segalàs C; Real E; Estivill X; Menchón JM
Eur Psychiatry; 2012 Jul; 27(5):386-90. PubMed ID: 22153732
[TBL] [Abstract][Full Text] [Related]
7. BDNF gene and obsessive compulsive disorder risk, symptom dimensions and treatment response.
Taj M J RJ; Ganesh S; Shukla T; Deolankar S; Nadella RK; Sen S; Purushottam M; Reddy YCJ; Jain S; Viswanath B
Asian J Psychiatr; 2018 Dec; 38():65-69. PubMed ID: 29079096
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived neurotrophic factor gene Val66Met polymorphism and cognitive function in obsessive-compulsive disorder.
Tükel R; Gürvit H; Ozata B; Oztürk N; Ertekin BA; Ertekin E; Baran B; Kalem SA; Büyükgök D; Direskeneli GS
Am J Med Genet B Neuropsychiatr Genet; 2012 Oct; 159B(7):850-8. PubMed ID: 22911909
[TBL] [Abstract][Full Text] [Related]
9. Exploring yale-brown obsessive-compulsive scale symptom structure in Iranian OCD patients using item-based factor analysis.
Asadi S; Daraeian A; Rahmani B; Kargari A; Ahmadiani A; Shams J
Psychiatry Res; 2016 Nov; 245():416-422. PubMed ID: 27620324
[TBL] [Abstract][Full Text] [Related]
10. Impact of brain-derived neurotrophic factor Val66Met polymorphism and response to escitalopram or paroxetine in obsessive-compulsive disorder.
Harika-Germaneau G; Langbour N; Patri S; Solinas M; Chatard A; Millet B; Hashemian F; Pérault-Pochat MC; Jaafari N; Lafay-Chebassier C
CNS Spectr; 2022 Oct; 27(5):645-651. PubMed ID: 34313207
[TBL] [Abstract][Full Text] [Related]
11. Factor analysis of Y-BOCS checklist and severity scale among patients with schizophrenia.
Grover S; Dua D; Chakrabarti S; Avasthi A
Asian J Psychiatr; 2017 Apr; 26():141-145. PubMed ID: 28483079
[TBL] [Abstract][Full Text] [Related]
12. Association study between BDNF gene variants and Mexican patients with obsessive-compulsive disorder.
Márquez L; Camarena B; Hernández S; Lóyzaga C; Vargas L; Nicolini H
Eur Neuropsychopharmacol; 2013 Nov; 23(11):1600-5. PubMed ID: 23999029
[TBL] [Abstract][Full Text] [Related]
13. The role of the brain-derived neurotrophic factor SNP rs2883187 in the phenotypic expression of obsessive-compulsive disorder.
Tükel R; Ozata B; Oztürk N; Ertekin BA; Ertekin E; Direskeneli GS
J Clin Neurosci; 2014 May; 21(5):790-3. PubMed ID: 24291483
[TBL] [Abstract][Full Text] [Related]
14. Do obsessive-compulsive disorder and Tourette syndrome share a common susceptibility gene? An association study of the BDNF Val66Met polymorphism in the Chinese Han population.
Liu S; Cui J; Niu Z; Yi M; Zhang X; Che F; Ma X
World J Biol Psychiatry; 2015; 16(8):602-9. PubMed ID: 25771937
[TBL] [Abstract][Full Text] [Related]
15. BDNF Val66Met modifies the risk of childhood trauma on obsessive-compulsive disorder.
Hemmings SM; Lochner C; van der Merwe L; Cath DC; Seedat S; Stein DJ
J Psychiatr Res; 2013 Dec; 47(12):1857-63. PubMed ID: 24050777
[TBL] [Abstract][Full Text] [Related]
16. Obsessive-compulsive disorder symptom dimensions show specific relationships to psychiatric comorbidity.
Hasler G; LaSalle-Ricci VH; Ronquillo JG; Crawley SA; Cochran LW; Kazuba D; Greenberg BD; Murphy DL
Psychiatry Res; 2005 Jun; 135(2):121-32. PubMed ID: 15893825
[TBL] [Abstract][Full Text] [Related]
17. Factor analysis of obsessive-compulsive disorder YBOCS-SC symptoms and association with 5-HTTLPR SERT polymorphism.
Hasler G; Kazuba D; Murphy DL
Am J Med Genet B Neuropsychiatr Genet; 2006 Jun; 141B(4):403-8. PubMed ID: 16583440
[TBL] [Abstract][Full Text] [Related]
18. Familiality of factor analysis-derived YBOCS dimensions in OCD-affected sibling pairs from the OCD Collaborative Genetics Study.
Hasler G; Pinto A; Greenberg BD; Samuels J; Fyer AJ; Pauls D; Knowles JA; McCracken JT; Piacentini J; Riddle MA; Rauch SL; Rasmussen SA; Willour VL; Grados MA; Cullen B; Bienvenu OJ; Shugart YY; Liang KY; Hoehn-Saric R; Wang Y; Ronquillo J; Nestadt G; Murphy DL;
Biol Psychiatry; 2007 Mar; 61(5):617-25. PubMed ID: 17027929
[TBL] [Abstract][Full Text] [Related]
19. Extensive genotyping of the BDNF and NTRK2 genes define protective haplotypes against obsessive-compulsive disorder.
Alonso P; Gratacòs M; Menchón JM; Saiz-Ruiz J; Segalàs C; Baca-García E; Labad J; Fernández-Piqueras J; Real E; Vaquero C; Pérez M; Dolengevich H; González JR; Bayés M; de Cid R; Vallejo J; Estivill X
Biol Psychiatry; 2008 Mar; 63(6):619-28. PubMed ID: 17884018
[TBL] [Abstract][Full Text] [Related]
20. The role of the COMT Val(158)Met polymorphism in the phenotypic expression of obsessive-compulsive disorder.
Katerberg H; Cath DC; Denys DA; Heutink P; Polman A; van Nieuwerburgh FC; Deforce DL; Bochdanovits Z; van Balkom AJ; den Boer JA
Am J Med Genet B Neuropsychiatr Genet; 2010 Jan; 153B(1):167-76. PubMed ID: 19521967
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
